Drug Trial Radar · NCT05984784
A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD)
Last checked: Nov 19, 2026Latest source record: Nov 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
13
Actual
Start
Aug 9, 2023
Primary completion
Apr 26, 2024
Study completion Apr 26, 2024
Sponsor
- Lead sponsor
- Inmagene LLCIndustry
- Sponsor type
- Industry
- First posted
- Aug 9, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 74 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate the safety of IMG-007 in adults with moderate-to-severe AD. The secondary objectives are to evaluate the pharmacokinetics and efficacy of IMG-007 in AD patients.
Conditions
- Atopic Dermatitis
- Moderate-to-severe Atopic Dermatitis
- AD
Interventions
PlaceboDrug
Drug: Placebo Intravenous Infusion
IMG-007Drug
Drug: IMG-007 Intravenous Infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluation of Adverse Events in ParticipantsTime frame: Adverse events were collected from baseline through the end of the study, a period of up to 24 weeks.
Locations
12 sites in 2 countries. Site status is shown where the registry gives one.
Amicis Research Center
Northridge, California
Amicis Research Center
Valencia, California
Medical Research Center of Miami II Inc
Miami, Florida
Optimal Research Sites
Orange City, Florida
USF Carol and Frank Morsani Center for Advanced Healthcare
Tampa, Florida
Revival Research Institute, LLC
Troy, Michigan
Markowitz Medical, LLC
New York, New York
Central Sooner Research
Oklahoma City, Oklahoma
Paddington Testing Co, Inc
Philadelphia, Pennsylvania
Centre de Recherche Saint-Louis (Québec)
Québec, Canada
Brunswick Dermatology Center
Fredericton, New Brunswick, Canada
DermEffects
London, Ontario, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.